Given that there is limited literature on the use of PERT in pancreatic cancer (PC), researchers from University of Tokyo aimed to investigate the potential benefits of this therapy in PC patients, especially those receiving chemotherapy. Read more . . .
For patients with advanced pancreatic cancer, pancreatic enzyme replacement therapy (PERT) may potentially improve nutritional status during chemotherapy, according to a study published in the journal Pancreas.